Copyright © 2001 by the European Society of Cardiology.
Editorials
Can metabolic manipulation reverse myocardial dysfunction?
Onassis Cardiac Centre, Athens, Greece
References
- Belardinelli R, Purcaro A. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy. Eur Heart J. 2001;22:21642170
[Abstract/Free Full Text] - Brottier L, Barat JL, Combe C, Boussens B, Bonnet J, Bricaud H. Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomypathy. Eur Heart J. 1990;11:207212
[Abstract/Free Full Text] - Lu C, Dabrowski P, Fragasso G, Chierchia S. Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease. Am J Cardiol. 1998;82:898901[CrossRef][ISI][Medline]
- Detry JM, Sellier P, Pennaforte S, Cokkinos D, Dargie H, Mathes P. Trimetazidine: a new concept in the treatment of angina: comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study group. Br J Clin Pharmacol. 1994;3:279288
- vom Dahl J, Altehoefer C, Sheehan F. Recovery of regional left ventricular dysfunction after coronary revascularization: impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol. 1996;28:948958[Abstract]
- Schulz R, Heusch G. Hibernating myocardium. Heart. 2000;84:587594
[Free Full Text] - Cokkinos DV, Athanassopoulos G, Karatasakis G. Role of myocardial viability in the improvement of cardiac function after revascularization. Heart Failure Rev. 1996;2:105113
- Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme a thiolase. Circ Res. 2000;86:580588
[Abstract/Free Full Text] - Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res. 1997;33:243257
[Free Full Text] - Rizos J. Three year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. Am Heart J. 2000;139:S120123[CrossRef][ISI][Medline]
- McCormack JG, Barr RL, Wolff AA, Lopaschuk GD. Ranolazine stimulates glucose oxidation in normoxic, ischemic and reperfused ischemic rat hearts. Circulation. 1996;93:135142
[Abstract/Free Full Text] - Allibardi S, Cherchia SL, Margonato V. Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts. Cardiovascular Drugs and Therapy. 1998;12:543549[CrossRef][ISI][Medline]
- Rinaldi CA, Linka AZ, Masani ND, Avery PG, Jones E, Saunders H, Hall RJC. Randomized, double-blind crossover study to investigate the effects of amlodipine and isosorbide mononitrate on the time course and severity of exercise-induced myocardial stunning. Circulation. 1998;98:749756
[Abstract/Free Full Text] - Tzivoni D, Maybaum S. Attenuation of severity of myocardial ischemia during repeated daily ischemic episodes. J Am Coll Cardiol. 1997;30:14261461[CrossRef][ISI][Medline]
- Minners J, van den Bos EJ, Yellon DM, Schwalb H, Opie LH, Sack MN. Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res. 2000;47:168173
- Gross GJ, Fryer RM. Sarcolemmal versus mitochondrial ATP sensitive K+ channels and myocardial preconditioning. Circ Res. 1999;84:973979
[Abstract/Free Full Text] - Schmidt-Schweda S, Holubarsch C. First clinical trial with etomoxir in patients with chronic congestive heart failure. Clin Sci. 2000;99:2735[Medline]
- Nagano M. Limited capacity for working overload in the V3 myosin-predominant rat heart. Exp Clin Cardiol. 2000;5:144148
- Jin H, Yang R, Awad TA. Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation. 2001;103:736742
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
L. H. Opie Preconditioning and metabolic anti-ischaemic agents Eur. Heart J., October 2, 2003; 24(20): 1854 - 1856. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
